Tachykinin NK1 receptor antagonist.
GR 82334 is a selective non-peptide antagonist of the neurokinin-1 (NK1) receptor, a G protein-coupled receptor (GPCR) that mediates the biological effects of substance P, a key neuropeptide involved in pain transmission, neurogenic inflammation, and various central and peripheral nervous system functions. As a small-molecule compound with high affinity and specificity for the NK1 receptor, GR 82334 offers researchers a powerful tool for dissecting the physiological and pathophysiological roles of substance P signaling. Its distinct chemical structure and pharmacological profile have made it a valuable asset in neuropharmacology, receptor characterization, and the study of neuropeptide-mediated processes.
Receptor Pharmacology: In receptor pharmacology studies, GR 82334 serves as a reference NK1 antagonist for characterizing the binding properties and signal transduction pathways of the neurokinin-1 receptor. By competitively inhibiting substance P-induced activation, it enables precise delineation of receptor-ligand interactions, downstream signaling cascades, and receptor subtype selectivity. Researchers utilize it to validate assay specificity, determine antagonist potency, and explore structure-activity relationships within the tachykinin receptor family.
Neurobiology Research: In the context of neurobiology, GR 82334 is widely employed to investigate the functional consequences of NK1 receptor blockade in neuronal circuits. Its use facilitates the elucidation of substance P's role in modulating synaptic transmission, neuronal excitability, and neuroplasticity. By incorporating this antagonist into in vitro and in vivo models, scientists can dissect the contribution of NK1-mediated signaling to pain pathways, stress responses, and neurogenic inflammation, advancing the understanding of sensory and affective processing.
Inflammation and Pain Mechanisms: The compound is instrumental in studies exploring the mechanistic links between neurokinin signaling and inflammatory processes. By selectively inhibiting NK1-mediated pathways, GR 82334 allows for the assessment of substance P's involvement in the initiation and propagation of neurogenic inflammation, vasodilation, and immune cell recruitment. Experimental models of inflammatory pain, edema, and tissue injury benefit from its use in clarifying the neuroimmune interface and identifying potential molecular targets for intervention.
Behavioral Pharmacology: GR 82334 is also employed in behavioral pharmacology to assess the impact of NK1 receptor antagonism on animal models of pain, anxiety, depression, and stress-related behaviors. Its ability to modulate substance P-driven neurotransmission provides a means to dissect the neurochemical substrates underlying affective and nociceptive states. Researchers leverage its selectivity to differentiate NK1-dependent effects from those mediated by other tachykinin receptors or neuromodulators, thereby refining the interpretation of behavioral outcomes.
Drug Discovery and Screening: In early-stage drug discovery, GR 82334 is frequently utilized as a benchmark compound for high-throughput screening and lead optimization efforts targeting the NK1 receptor. Its well-characterized pharmacological profile aids in the validation of assay systems, comparison of novel antagonists, and assessment of off-target effects. By serving as a standard reference, it contributes to the rigorous evaluation of candidate molecules and supports the development of innovative agents modulating neurokinin signaling for research purposes.
2. Cationic cell-penetrating peptides are potent furin inhibitors
4. Emu oil in combination with other active ingredients for treating skin imperfections
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More